According to Pharmatimes.com, “The UK is paying less for new cancer drugs than most other countries in Europe, a new report has found. The study in The Lancet Oncology also reveals that the prices of such drugs vary widely – from 28 percent to 388 percent – between high-income European countries, Australia, and New Zealand.” […]
The post ICYMI: UK Paying Less for Cancer Drugs Than Other EU Countries appeared first on Q1 Productions.
